Table 2.
Number of patients seen by the interviewees
| All ophthalmologists | University hospital ophthalmologists | Nonacademic hospital ophthalmologists | Clinic ophthalmologists | |
|---|---|---|---|---|
| Weekly number of patients with ophthalmic conditions | ||||
| ≥201 | 4 | 1 | 1 | 2 |
| 101–200 | 8 | 3 | 4 | 1 |
| ≤100 | 6 | 3 | 2 | 1 |
| Weekly number of wAMD patients (%) | ||||
| ≥70% | 4 | 4 | 0 | 0 |
| 30%–69% | 4 | 3 | 1 | 0 |
| ≤29% | 10 | 0 | 6 | 4 |
| Experience with proactive treatment (number of patients)a | ||||
| ≥101 | 10 | 7 | 2 | 1 |
| 11–100 | 3 | 0 | 2 | 1 |
| ≤10 | 5 | 0 | 3 | 2 |
Note:
a
Proactive treatment includes both fixed-dosing and T&E.
Abbreviations: T&E, treat-and-extend; wAMD, wet age-related macular degeneration.